🆕study led by CP3’s @bryantshuey.bsky.social finds employer-mandated switches to high-deductible plans were linked to delays in OUD-related high-acuity care and 37% fewer high-acuity care days, raising concerns about cost-sharing barriers to timely treatment. journals.lww.com/journaladdic...

The agenda for @cpddorg.bsky.social #cpdd26 is out, and we can't wait to join our colleagues from @brownpublichealth.bsky.social to share lessons learned from implementing #machinelearning driven #overdose prevention interventions! cpdd.societyconference.com/conf/#sessio...

New @plosone.org study finds long-term opioid therapy is linked to higher risk of infection-related dental outcomes in a national VA cohort, underscoring oral health risks in chronic opioid users. CP3's Dr. Katie Suda is a co-author. journals.plos.org/plosone/arti...

CP3's @timandersonmd.bsky.social spoke with @statnews.com about the importance of conversations between patient and prescriber when making decisions about statins and other medications. Read more: www.statnews.com/2026/02/05/s...

🆕paper co-authored by CP3’s @timandersonmd.bsky.social highlights how longer life expectancy has expanded the number of older adults with CVD risk. Using the Geriatric 5Ms, it reviews new BP & lipid guidelines to support personalized prevention in aging adults. www.sciencedirect.com/science/arti...

ICYMI: CP3's Dr. Tom Radomski reflects on moving from student to associate director of Pitt's ICRE in Pitt Med magazine. (Bonus cameos of CP3 Director @walidgellad.bsky.social & faculty affiliate Dr. Julie Donohue!) www.pittmed.pitt.edu/news/institu...

Our latest newsletter is live! Through the holiday break and a huge winter storm, we kept busy! createsend.com/t/j-DBA41D16...

🆕study by CP3’s @timandersonmd.bsky.social shows that even when discharge summaries and instructions align, older adults misunderstood >50% of cardiometabolic 💊 changes. Concordance doubled understanding but clearer discharge communication needed. agsjournals.onlinelibrary.wiley.com/doi/10.1111/...

CP3 Director @walidgellad.bsky.social will moderate a panel at the Novel Solutions to Address the Rising Cost of Oncology Drugs conference, hosted by the University of Chicago & Georgetown Law, focused on demand-side strategies to improve cancer drug affordability. cpt.uchicago.edu/program/

🆕 Study co-authored by CP3’s @jennylociganic.bsky.social used EHR data to build #machinelearning models predicting which patients receive pharmacogenetic testing for #opioid therapy. Results show strong performance and promise for precision pain care. medinform.jmir.org/2026/1/e81048

🆕study co-authored by CP3’s @walidgellad.bsky.social & Noah Feder finds only ~30% of hospitals fully comply with CMS price transparency rules, with most failing to report negotiated rates. PPS-exempt hospitals showed similar gaps. www.sciencedirect.com/science/arti...

New @arstechnica.com piece highlights work by CP3’s @timandersonmd.bsky.social showing that #GLP-1 drugs improve heart health, but benefits fade when treatment stops—raising important questions about long-term use, adherence, and chronic disease management. arstechnica.com/health/2025/...

🆕study co-authored by CP3’s @timandersonmd.bsky.social finds current transitions of care programs are fragmented, harming pt handoffs. Improving outcomes will require addressing social needs, stronger leadership support, & pt-centered care. shmpublications.onlinelibrary.wiley.com/doi/10.1002/...

New study co-authored by CP3’s Dr. Ted Park finds postoperative opioid and benzodiazepine prescribing often mirrors patients’ pre-surgery use rather than new surgical needs. Understanding these patterns is key to tailoring surgery-specific interventions. journals.lww.com/journalacs/a...

Our team worked with partners at ACDHS to develop a risk prediction model to determine risk of overdose after a person leaves jail. Time spent in a carceral setting has a huge impact on people's vulnerability. cp3.pitt.edu/allegheny-co...

We love seeing CP3's Dr. Sarah Belcher & Dr. Luke Berenbrok's work highlighted in Pitt Research's Annual Report! We continue to make impact on healthcare! Dr. Belcher: www.research.pitt.edu/report/impro... Dr. Berenbrok: www.research.pitt.edu/report/impro...

We're so happy that @drjuanhc.com is officially part of Pitt and CP3! Our work together will be even stronger with you here, Juan!

Excited to start the year by planning to share our #riskprediction work at 2 conferences: @upmc.com Digital Health Summit & @cpddorg.bsky.social #cpdd36! At #cpdd26, we'll join colleagues from @brownpublichealth.bsky.social to share lessons learned from our experience doing this work. See you there!

New study co-authored by CP3’s Dr. Julie Donohue highlights Medicaid’s crucial role in covering seriously ill adults and shows the need for Medicaid programs to focus more on ICU patients before, during, and after hospitalization to improve care and outcomes. pmc.ncbi.nlm.nih.gov/articles/PMC...

New national study shows alcohol-related hospitalizations stayed stable from 2016–2022, but mortality, length of stay, & costs rose. Findings highlight the need for prevention & earlier AUD treatment to improve outcomes & reduce spending. @timandersonmd.bsky.social jamanetwork.com/journals/jam...

Many older adults are stopping their #GLP-1 medications. @nytimes.com spoke with experts, including CP3's @timandersonmd.bsky.social to learn more. @pittdeptofmed.bsky.social @pittgim.bsky.social www.nytimes.com/2025/12/21/h...

More than 1 in 10 older adults in Medicare Part D Medication Therapy Management use multiple CNS meds, increasing fall risk, yet only ~1/3 get a comprehensive med review. Better engagement needed to reduce risk. @timandersonmd.bsky.social www.jmcp.org/doi/10.18553...

Congrats to Yujin Seo (CMU), working with CP3’s Dr. Katie Suda, on presenting at the IQVIA Institute Research Forum. Her poster shows drug shortages hit older adults hardest, with faster fill declines among Medicare/Medicaid patients and those linked to rural or lower-income prescribers.

New study co-authored by CP3’s @timandersonmd.bsky.social shows limited lecanemab uptake in the VHA and that nearly 30% of patients had ARIA or stroke within 7 months of starting treatment, highlighting the need for careful long-term safety and effectiveness monitoring. www.mdpi.com/2077-0383/14...

Welcome to CP3! Juan M. Hincapie-Castillo (@drjuanhc.com) will join Pitt’s School of Pharmacy as Associate Professor (pending) in Jan 2026 & as a CP3 faculty affiliate. A longtime collaborator & 2024 Pharmacoequity panelist, his work focuses on legal epidemiology & evidence-based policymaking.

🆕study in @addictionjournal.bsky.social shows how lookback window & washout choices in MOUD research affect sample size, demographics, & tx start misclassification. It offers practical guidance to improve comparative studies in #opioid use disorder research. onlinelibrary.wiley.com/doi/10.1111/...

CP3 Associate Director Dr. Katie Suda was interviewed for Dr. Bicuspid on the risks of prescribing #opioids to pediatric patients. Read the interview and more on Dr. Suda's study here: www.drbicuspid.com/dental-speci...

New study finds telehealth and a gradual return to in-person visits helped restore outpatient care for patients with atrial fibrillation after the pandemic. But recovery was uneven, with notable differences by patients’ pre-pandemic outpatient use. link.springer.com/article/10.1...

🆕study finds global #drugshortages persist & disproportionately affect countries with lower GDP per capita. Essential medicines are unevenly impacted worldwide, highlighting the need for policy solutions beyond pricing to address shortages & global inequities. gh.bmj.com/content/10/1...

We had a fun watch party for our friend and colleague Dr. Lu Tang's Senior Vice Chancellor’s Research Seminar! We've been lucky to work with Dr. Tang on our risk prediction projects and enjoyed his amazing talk on innovative analytic methods for precision health care! @pittmed.bsky.social

New study led by CP3’s Dr. Jenny Lo-Ciganic presents a dynamic risk model that efficiently identifies older adults at high fall-related injury risk—offering a tool to inform clinical decisions and better target prevention resources. accpjournals.onlinelibrary.wiley.com/doi/10.1002/...

🆕 @jamahealthforum.com study of 13.8M ARB users found adherence didn’t change 18 months after the recalls, many switched to alternatives within 90 days, & switching didn’t raise insurer or out-of-pocket drug costs. jamanetwork.com/journals/jam...

Using real-world data, our colleagues (including CP3's Dr. Jenny Lo-Ciganic) found for PPH, the top-ranked risk factor was placenta previa or accreta, the top-ranked comorbidity was primary cesarean delivery, & the commonest cause was uterine atony. Read more: www.researchsquare.com/article/rs-7...

CP3's Dr. Jenny Lo-Ciganic was part of a team that examined associations between trajectories of #buprenorphine use & time to adverse outcomes among youth. Bottom line: Medication adherence may prevent overdose, ED use, and hospitalization. Read more: publications.aap.org/pediatrics/a...

CP3's @timandersonmd.bsky.social was lead author on this paper describing study results including that most hospitalized older adults discharged w/cardiometabolic 💊 changes experienced 💊 errors or gaps in discharge planning. Read more @journalgim.bsky.social: link.springer.com/article/10.1...

Growing use of antiobesity medications means that clinicians must be aware of risks and benefits of starting & stopping them. In @jamainternalmed.com, Dr. Elizabeth Oczypok & CP3's @timandersonmd.bsky.social share important lessons gleaned from research settings. jamanetwork.com/journals/jam...

The DEMONSTRATE trial will assess a #MachineLearning based clinical decision support tool to reduce #opioid harm in elevated risk patients. This paper describes the protocol that will provide real-world evidence for the tool. Read more: www.mdpi.com/2077-0383/14...

CP3's Dr. Luke Berenbrok spoke with @newsweek.com about ways #Medicare users can ensure they are using all of their benefits, especially those for OTC items. He suggests talking with community pharmacists for help with understanding what products are covered. www.newsweek.com/medicare-use...

CP3’s Dr. Julie Donohue and colleagues urge continued investment in strong, objective health policy research—calling for innovative methods and data sources to guide the future of health care and strengthen the evidence base. Read more @jamahealthforum.com: jamanetwork.com/journals/jam...

🆕 @jamainternalmed.com, CP3's @bryantshuey.bsky.social, @timandersonmd.bsky.social, & Dr. Ted Park break down new ASAM #benzodiazepine tapering guidelines, highlighting how to support safer #deprescribing, especially for high-risk patients. jamanetwork.com/journals/jam... @pittgim.bsky.social

Have you heard of Pitt's Healthy Home Lab? It's one of the innovations led by our parent org, Pitt's Health Policy Institute. In @publicsource.org, read about it and other solutions to help older adults: www.publicsource.org/pennsylvania...

ICYMI: CP3's @bryantshuey.bsky.social was recently chosen as a @nam.edu State Health Policy Fellow. Dr. Shuey will use his expertise in addiction issues to advise the PA Department of Health's Office of Drug Surveillance and Misuse Prevention. www.medschool.pitt.edu/news/bryant-...

🆕editorial co-authored by CP3’s Dr. Julie Donohue argues that as health policy enters a turbulent era, research must focus not only on access, cost, & quality, but also on system innovations, SDoH, & emerging tools like AI. @jamahealthforum.com: jamanetwork.com/journals/jam...

🆕study co-authored by CP3’s Dr. Bernie Good finds that a targeted pharmacy-care-management service ⬆️💊 adherence & ⬇️resource use among Medicare Advantage beneficiaries—supporting broader use of pharmacist-led models in managing cardiometabolic conditions. Read more: www.jmcp.org/doi/10.18553...

New study co-authored by CP3’s Dr. Katie Suda found repeat C. difficile testing within 7 days was uncommon (4.5%) but more frequent in long-term care and among resident-ordered tests—highlighting opportunities to strengthen diagnostic stewardship. www.cambridge.org/core/journal...

New study from CP3 finds buprenorphine initiation in older adults rose in 2018–19 but plateaued thru 2021 despite access efforts—showing need for targeted implementation & clinician education to boost MOUD use. @agsjournal.bsky.social agsjournals.onlinelibrary.wiley.com/doi/full/10....

New study co-authored by CP3’s Dr. Katie Suda & Yilei Liu found that 1 in 10 pediatric dental visits involving opioids led to overdose or persistent use—highest in young children. Highlights need for caution and nonopioid pain management. pubmed.ncbi.nlm.nih.gov/41081662/

New study co-authored by CP3’s Dr. Katie Suda found that antibiotic durations for common infections in older adults are often longer than guidelines recommend, highlighting opportunities to reduce overuse and improve antimicrobial stewardship. pubmed.ncbi.nlm.nih.gov/41050542/

New study co-authored by CP3’s Dr. Tom Radomski finds standard criteria for medication appropriateness may not align w/shifting goals of care in dementia. Integrating goals-of-care data could improve 💊optimization. More @agsjournal.bsky.social: agsjournals.onlinelibrary.wiley.com/doi/10.1111/...

Congratulations to our colleague @mirandayaver.bsky.social for being named one of the @academyhealth.bsky.social Champions for Health Services & Prevention Research! Well deserved! academyhealth.org/page/champio...